Amynas

Foundation date

23/12/2019

Sector

#Medical Technology

Subsector

Amynas’ lead candidate product is a bio-envelope made of electrospun nanofibers designed to promote healthy tissue growth around the implant (anti-inflammatory and anti-scarring) and reduce the infection rate, resulting in fewer re-admission rates for post-surgical complications.

Upcoming events

Latest news

  • Indigo Diabetes announces first participant enrolled in the SHINE clinical trial

    18 hours ago

  • FINTEPLA®▼ (fenfluramine) approved in Japan for the treatment of seizures associated with Dravet syndrome

    Tuesday September 27th 2022

  • Pauwels Consulting takes over Science@Work

    Friday September 23rd 2022